the prevalence of APOL1 high risk alleles in dialysis population in the Netherlands

the prevalence of APOL1 high risk alleles in dialysis population in the Netherlands - the prevalence of APOL1 in dialysis population

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54657

Enrollment

500

Registered

2020-06-18

Start date

2020-10-20

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney failure kidney insufficiency

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: all adults on dialysis with given informed consent

Exclusion criteria

Exclusion criteria: all patients who dit not give informed consent

Design outcomes

Primary

Measure	Time frame
the primary outcome is the proportion of two high risks alleles of APOL1 gene in patients on dialysis in the Netherlands	—

Secondary

Measure	Time frame
The secondary outcome is the proportion of the two high risk alleles of APOL1 gene in patients on dialysis from Western Africa, Suriname, the Netherlands Antilles and Moroccan and compare this to dialysis patients from Caucasian background. In addition, the prevalence of kidney disease related monogenic or polygenic mutations in the dialysis population of Amsterdam and Utrecht.	—

Countries

Netherlands

Outcome results